ClinicalTrials.Veeva

Menu

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Novartis logo

Novartis

Status and phase

Completed
Phase 3

Conditions

Hypertension

Treatments

Drug: valsartan/amlodipine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00171002
CVAA489A2306

Details and patient eligibility

About

This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication

Enrollment

936 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with uncomplicated, essential hypertension

Exclusion criteria

  • Severe hypertension
  • History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
  • Liver, kidney, or pancreas disease
  • Insulin dependent diabetes
  • Allergy to certain medications used to treat high blood pressure

Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems